Great news...
Confirmation That BLA is targeted to submit within 5 weeks, and that CLBP trial design should also be submitted within 5 weeks.
CLBP USA trial to start Q2 23.
CHF RMAT meeting Q1 23 estimated ( awaiting FDA to confirm the dates )
I want to know - can the company request the investigator crohns control arm results !
Ann: Long-Term Survival for Acute GvHD Treatment with Remestemcel, page-33
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.42 |
Change
-0.045(3.07%) |
Mkt cap ! $1.581B | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.46 | $1.37 | $5.105M | 3.636M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 12905 | $1.42 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.42 | 21910 | 6 |
View Market Depth
| Last trade - 12.36pm 09/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |